DANIELA QUINTANA: Open Payments
NPI 1013572536 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$215 in 12 payments from 9 companies in 2025. Trend: 2023 $58 · 2024 $191 · 2025 $215
Food & beverage: $215
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $80 |
| Novo Nordisk Inc | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $14 |
| CVRx, Inc. | 1 | $9 |
Products named: VYNDAQEL, Wegovy, LEQVIO, FARXIGA, NEXLETOL, REPATHA, ELIQUIS, VERQUVO.
Industry payments across FL — which companies pay providers there.
